Bertil Abrahamsson

8.7k total citations · 1 hit paper
132 papers, 6.3k citations indexed

About

Bertil Abrahamsson is a scholar working on Pharmaceutical Science, Analytical Chemistry and Oncology. According to data from OpenAlex, Bertil Abrahamsson has authored 132 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Pharmaceutical Science, 34 papers in Analytical Chemistry and 30 papers in Oncology. Recurrent topics in Bertil Abrahamsson's work include Drug Solubulity and Delivery Systems (91 papers), Analytical Methods in Pharmaceuticals (34 papers) and Advanced Drug Delivery Systems (32 papers). Bertil Abrahamsson is often cited by papers focused on Drug Solubulity and Delivery Systems (91 papers), Analytical Methods in Pharmaceuticals (34 papers) and Advanced Drug Delivery Systems (32 papers). Bertil Abrahamsson collaborates with scholars based in Sweden, Germany and United States. Bertil Abrahamsson's co-authors include Jennifer Dressman, Hans Lennernäs, Christos Reppas, Konstantinos Goumas, James G. Brasseur, Anders S. Carlsson, Lida Kalantzi, Tiago Sousa, Abdul W. Basit and Anupam Pal and has published in prestigious journals such as Gastroenterology, Journal of Controlled Release and Proceedings of the Royal Society B Biological Sciences.

In The Last Decade

Bertil Abrahamsson

131 papers receiving 6.1k citations

Hit Papers

Characterization of the Human Upper Gastrointestinal Cont... 2005 2026 2012 2019 2005 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Characterization of the Human Upper Gastrointestinal Contents Under Conditions Simulating Bioavailability/Bioequivalence Studies
    2005 525 citations Lida Kalantzi, Konstantinos Goumas et al. Pharmaceutical Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bertil Abrahamsson Sweden 44 3.6k 1.2k 1.1k 982 895 132 6.3k
Joachim Brouwers Belgium 39 3.6k 1.0× 858 0.7× 860 0.8× 1.5k 1.5× 485 0.5× 110 5.2k
Maria Vertzoni Greece 35 3.0k 0.8× 552 0.5× 654 0.6× 1.0k 1.1× 624 0.7× 114 4.1k
Peter Langguth Germany 50 3.3k 0.9× 2.2k 1.9× 1.9k 1.7× 1.0k 1.0× 315 0.4× 271 9.1k
Christos Reppas Greece 45 6.6k 1.8× 1.2k 1.0× 1.5k 1.4× 2.4k 2.4× 1.1k 1.3× 152 9.0k
René Holm Denmark 46 4.7k 1.3× 1.9k 1.6× 1.1k 1.0× 1.9k 1.9× 244 0.3× 266 8.3k
Arik Dahan Israel 48 3.3k 0.9× 1.3k 1.1× 1.9k 1.7× 945 1.0× 223 0.2× 135 6.6k
Shinji Yamashita Japan 42 2.9k 0.8× 1.4k 1.2× 1.6k 1.5× 862 0.9× 171 0.2× 167 5.8k
Anette Müllertz Denmark 60 7.3k 2.0× 2.1k 1.8× 1.7k 1.6× 2.1k 2.1× 450 0.5× 274 11.2k
Raimar Löbenberg Canada 39 3.5k 1.0× 1.3k 1.1× 573 0.5× 1.2k 1.2× 159 0.2× 197 6.8k
John R. Crison United States 20 3.4k 0.9× 941 0.8× 922 0.9× 1.5k 1.6× 147 0.2× 31 5.3k

Countries citing papers authored by Bertil Abrahamsson

Since Specialization
Citations

This map shows the geographic impact of Bertil Abrahamsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertil Abrahamsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertil Abrahamsson more than expected).

Fields of papers citing papers by Bertil Abrahamsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertil Abrahamsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertil Abrahamsson. The network helps show where Bertil Abrahamsson may publish in the future.

Co-authorship network of co-authors of Bertil Abrahamsson

This figure shows the co-authorship network connecting the top 25 collaborators of Bertil Abrahamsson. A scholar is included among the top collaborators of Bertil Abrahamsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertil Abrahamsson. Bertil Abrahamsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Engman, Helena, Sara Carlert, Richard A. Barker, et al.. (2025). Leveraging Biopharmaceutics Bridging Risk Assessment and In Vivo Predictive Tools to Accelerate Immediate Release Drug Product Development by Minimized Need for Clinical Bridging Studies. Molecular Pharmaceutics. 22(10). 6203–6214. 1 indexed citations
2.
Sousa, Tiago, et al.. (2025). Evaluating rat and canine microbiota models for predicting human colonic prodrug metabolism. European Journal of Pharmaceutical Sciences. 214. 107273–107273.
3.
Abrahamsson, Bertil, Naseem A. Charoo, Rodrigo Cristofoletti, et al.. (2024). Biowaiver monographs for immediate-release solid oral dosage forms: Voriconazole. Journal of Pharmaceutical Sciences. 114(2). 660–680. 4 indexed citations
4.
Abrahamsson, Bertil, Naseem A. Charoo, Rodrigo Cristofoletti, et al.. (2024). Biowaiver monographs for immediate-release solid oral dosage forms: Lemborexant. Journal of Pharmaceutical Sciences. 114(2). 644–659. 1 indexed citations
5.
Nyström, Lina, Isabel Mira, J. Benjamins, et al.. (2023). In Vitro and In Vivo Performance of Pickering Emulsion-Based Powders of Omega-3 Polyunsaturated Fatty Acids. Molecular Pharmaceutics. 21(2). 677–687. 4 indexed citations
6.
Abrahamsson, Bertil, Patrick Augustijns, Thomas Gießmann, et al.. (2022). Application of In Vivo Imaging Techniques and Diagnostic Tools in Oral Drug Delivery Research. Pharmaceutics. 14(4). 801–801. 10 indexed citations
7.
Pieterman, Elsbet, P. Hans, Magnus J. Johansson, et al.. (2021). Effects of mineral oil administration on the pharmacokinetics, metabolism and pharmacodynamics of atorvastatin and pravastatin in mice and dogs. European Journal of Pharmaceutical Sciences. 161. 105776–105776. 10 indexed citations
8.
Augustijns, Patrick, Maria Vertzoni, Christos Reppas, et al.. (2020). Unraveling the behavior of oral drug products inside the human gastrointestinal tract using the aspiration technique: History, methodology and applications. European Journal of Pharmaceutical Sciences. 155. 105517–105517. 22 indexed citations
9.
Andreas, Cord J., James Butler, Patrick Augustijns, et al.. (2018). Introduction to the OrBiTo decision tree to select the most appropriate in vitro methodology for release testing of solid oral dosage forms during development. European Journal of Pharmaceutics and Biopharmaceutics. 130. 207–213. 32 indexed citations
10.
Nawroth, Thomas, et al.. (2016). A Novel Disintegration Tester for Solid Dosage Forms Enabling Adjustable Hydrodynamics. Journal of Pharmaceutical Sciences. 105(8). 2402–2409. 11 indexed citations
11.
Wachtel, Herbert, et al.. (2015). Computational Fluid Dynamics Simulation of Hydrodynamics and Stresses in the PhEur/USP Disintegration Tester Under Fed and Fasted Fluid Characteristics. Journal of Pharmaceutical Sciences. 104(9). 2956–2968. 21 indexed citations
12.
Tannergren, Christer, et al.. (2013). Evaluation of an in vitro faecal degradation method for early assessment of the impact of colonic degradation on colonic absorption in humans. European Journal of Pharmaceutical Sciences. 57. 200–206. 23 indexed citations
13.
Holm, René, et al.. (2013). Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS. European Journal of Pharmaceutical Sciences. 57. 232–239. 67 indexed citations
14.
Carlert, Sara, Hans Lennernäs, & Bertil Abrahamsson. (2013). Evaluation of the use of Classical Nucleation Theory for predicting intestinal crystalline precipitation of two weakly basic BSC class II drugs. European Journal of Pharmaceutical Sciences. 53. 17–27. 22 indexed citations
15.
Larsen, Anne, Richard A. Barker, Andrew R. Phillips, et al.. (2012). Oral bioavailability of cinnarizine in dogs: Relation to SNEDDS droplet size, drug solubility and in vitro precipitation. European Journal of Pharmaceutical Sciences. 48(1-2). 339–350. 88 indexed citations
16.
Borde, Annika, Εva Karlsson, Kent Andersson, et al.. (2011). Assessment of enzymatic prodrug stability in human, dog and simulated intestinal fluids. European Journal of Pharmaceutics and Biopharmaceutics. 80(3). 630–637. 33 indexed citations
17.
Kalantzi, Lida, Eva Persson, Bertil Abrahamsson, et al.. (2006). Canine Intestinal Contents vs. Simulated Media for the Assessment of Solubility of Two Weak Bases in the Human Small Intestinal Contents. Pharmaceutical Research. 23(6). 1373–1381. 132 indexed citations
18.
Madhu, Basetti, et al.. (2002). A novel evaluation of subcutaneous formulations by in vivomagnetic resonance imaging (MRI). Pharmacological Research. 45(3). 207–212. 7 indexed citations
19.
Aberg, Judith A., Bertil Abrahamsson, Margaretha Grind, G. Nyberg, & Bertil Olofsson. (1997). Bioequivalence, pharmacokinetic and pharmacodynamic response to combined extended release formulations of felodipine and metoprolol in healthy volunteers. European Journal of Clinical Pharmacology. 52(6). 471–477. 9 indexed citations
20.
Abrahamsson, Bertil, et al.. (1996). Gastro-intestinal transit of a multiple-unit formulation (metoprolol CR/ZOK) and a non-disintegrating tablet with the emphasis on colon. International Journal of Pharmaceutics. 140(2). 229–235. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joachim Brouwers Breakdown of academic impact, for papers by Maria Vertzoni Breakdown of academic impact, for papers by Peter Langguth Breakdown of academic impact, for papers by Christos Reppas Breakdown of academic impact, for papers by René Holm Breakdown of academic impact, for papers by Arik Dahan Breakdown of academic impact, for papers by Shinji Yamashita Breakdown of academic impact, for papers by Anette Müllertz Breakdown of academic impact, for papers by Raimar Löbenberg Breakdown of academic impact, for papers by John R. Crison
Rankless by CCL
2026